Experience

Davis Polk advised Auris Medical Holding AG on its $10 million public offering of 10,000,000 of its common shares and 10,000,000 warrants, each warrant entitling its holder to purchase 0.7…

Davis Polk advised the initial purchasers in connection with a Rule 144A/Regulation S offering by Banco Supervielle S.A. of an aggregate principal amount of approximately ARS 4.8 billion (…

Davis Polk advised Affimed N.V. on its $18 million public offering of 10,000,000 of its common shares. The underwriters have a 30-day option to purchase an additional 1,500,000 shares. The…

Davis Polk advised Banco Santander Chile in connection with its Regulation S offering in Taiwan of $185 million aggregate principal amount of floating-rate notes due 2021.  Banco…

Davis Polk advised Banco Santander Chile in connection with its Regulation S offering in Switzerland of CHF125 million aggregate principal amount of 0.350% fixed-rate notes due 2025.  …

Davis Polk advised Brinker International, Inc. in connection with its Rule 144A/Regulation S offering of $350 million aggregate principal amount of 5.000% senior notes due 2024. The…

Davis Polk advised the sole book-running manager and representative of the several underwriters in connection with a $63.3 million SEC-registered offering of 6,325,000 shares of common…

Davis Polk advised the joint bookrunning managers in connection with a Rule 144A offering by Blackhawk Network Holdings, Inc. of $500 million aggregate principal amount of 1.50% convertible…

Davis Polk advised the joint bookrunners in connection with a Rule 144A offering by The Medicines Company of $402.5 million aggregate principal amount of 2.75% convertible senior notes due…

Davis Polk advised the joint bookrunners and joint global coordinators of the several underwriters in connection with the international initial public offering by Grupo Supervielle S.A…